$ADNH Balance Sheet | Understand Stock

$ADNH

$0.00 -$0.00 (16.67%) Close

$ADNH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q2 FY2024 As of Jun 30, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020
ASSETS
Current assets:
Cash
Prepaid income tax
Cash and cash equivalents
Restricted cash, current
Accounts receivable, net
Due from related parties
Contract assets
Inventories
Prepaid expenses and Other current assets
Assets of discontinued operations
Total current assets

Cash and cash equivalents held in Trust Account
Non-current assets:
Goodwill and intangibles, net
Net Carrying Amount
Intangibles, net
Property and equipment, net
Right-of-use assets
Restricted cash, non-current
Other non-current assets
Deferred tax assets
Available for sale financial asset
Assets of discontinued operations
Total non-current assets

Total assets

LIABILITIES AND STOCKHOLDERS’ EQUITY/(DEFICIT)
Current liabilities:
Trade and other payables
Accrued expenses
Franchise tax payable
Due to related parties
Deferred income from grants, current
Contract liabilities
Loss contingency liabilities
Other current liabilities
Operating lease liabilities
Short-term loan payable, net of discount
Income tax payable
Promissory note
Promissory note- Related party
Liabilities of discontinued operations
Total current liabilities

Deferred underwriting fees
Non-current liabilities:
Bonds and other long-term debt, net
Warrant liability
Deferred tax liabilities
Long-term operating lease liabilities
Defined benefit obligation
Deferred income from grants, non-current
Other long-term liabilities
Total non-current liabilities

Total liabilities
Common stock subject to possible redemption, 7,560,480 and 20,846,454 shares at redemption value at December 31, 2020 and December 31, 2019, respectively

Stockholders’ equity/(deficit)
Common stock ($0.0001 par value per share; Shares authorized: 500,000,000 at September 30, 2025 and December 31, 2024; Issued and outstanding: 3,291,634 and 2,636,508 at September 30, 2025 and December 31, 2024, respectively)
Class A Common Stock
Class B Common Stock
Total common stock ($0.0001 par value per share; Shares authorized: 500,000,000 at September 30, 2025 and December 31, 2024; Issued and outstanding: 3,291,634 and 2,636,508 at September 30, 2025 and December 31, 2024, respectively)

Preferred stock ($0.0001 par value per share; Shares authorized: 1,000,000 at September 30, 2025 and December 31, 2024; nil 0 issued and outstanding at September 30, 2025 and December 31, 2024)
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders’ equity/(deficit)

Total liabilities and stockholders’ equity/(deficit)

Comments